Heat shock protein 70 and cellular disturbances in cochlear cisplatin ototoxicity model.
García-Berrocal
José Ramón
JR
Department of Otorhinolaryngology, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain. jrgarciab@yahoo.com
Nevado
J
J
González-García
J A
JA
Sánchez-Rodríguez
C
C
Sanz
R
R
Trinidad
A
A
España
P
P
Citores
M J
MJ
Ramírez-Camacho
R
R
D000818:Animals; D000970:Antineoplastic Agents / Q000633:toxicity*; D017209:Apoptosis / Q000187:drug effects; D002945:Cisplatin / Q000633:toxicity*; D003051:Cochlea / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D015853:Cysteine Proteinase Inhibitors / Q000494:pharmacology; D004195:Disease Models, Animal; D016057:Evoked Potentials, Auditory, Brain Stem / Q000187:drug effects; D018840:HSP70 Heat-Shock Proteins / Q000378:metabolism*; D007274:Injections, Intraperitoneal; D009842:Oligopeptides / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013482:Superoxide Dismutase / Q000187:drug effects / Q000378:metabolism
D000970:Antineoplastic Agents; D015853:Cysteine Proteinase Inhibitors; D018840:HSP70 Heat-Shock Proteins; D009842:Oligopeptides; C110772:benzoylcarbonyl-aspartyl-glutamyl-valyl-aspartyl-fluoromethyl ketone; D013482:Superoxide Dismutase; D002945:Cisplatin